First Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Front Immunol. 2022 Apr 14;13:881321. doi: 10.3389/fimmu.2022.881321. eCollection 2022.
The extent of the increase in postpartum alanine transaminase (ALT) varies significantly among pregnant women in the immune tolerance stage of nucleoside analogue (NA) intervention, so this study is an attempt to analyze the clinical features of patients with and without postpartum hepatitis flare and preliminarily explore the differences in their immune functions.
Pregnant women with a gestational age of 24-28 w and in the immune tolerance stage of NA intervention for hepatitis B virus (HBV) infection were included and divided into a hepatitis group (Group 1) and a nonhepatitis group (Group 2) according to the ALT level at 6-12 w after childbirth. The clinical features were analyzed, and the phenotypes, functions, and cytokines of clusters of differentiation CD8 T cells in the two groups of patients were detected using flow cytometry before and after childbirth.
A total of 15 patients with postpartum hepatitis flare were enrolled in Group 1, and 10 matched patients were selected as controls for Group 2. Compared with the individuals in Group 2, the postpartum clinical features in Group 1 included a remarkable elevation of the ALT level on the basis of a relatively low HBV DNA level, usually accompanied by a decline in hepatitis B virus surface antigen levels as well as HBeAg levels. In addition, CD8 T cell activation was enhanced after childbirth in Group 1. In particular, there was a notable difference in the activation of TEMRA subsets, and the frequency of CD8 T cells expressing perforin and granzyme B increased.
The changes in the immune characteristics of CD8 T cells may play a certain role in breaking down immune tolerance in patients with postpartum hepatitis flare, and the indexes related to activating and killing functions may help to indicate the population with hepatitis flare after childbirth.
核苷(酸)类似物(NA)干预免疫耐受期孕妇产后丙氨酸氨基转移酶(ALT)升高幅度差异较大,本研究试图分析产后肝炎发作患者与无肝炎发作患者的临床特征,并初步探讨其免疫功能的差异。
纳入妊娠 24-28 周、NA 干预免疫耐受期的乙肝病毒(HBV)感染孕妇,根据产后 6-12 周 ALT 水平分为肝炎组(Group 1)和非肝炎组(Group 2)。分析两组患者的临床特征,采用流式细胞术检测两组患者产后 CD8 T 细胞表型、功能及细胞因子。
共纳入 15 例产后肝炎发作患者为 Group 1,选择 10 例匹配患者为 Group 2。与 Group 2 相比,Group 1 患者产后除 HBV DNA 水平相对较低外,ALT 水平显著升高,通常伴有乙肝表面抗原和 HBeAg 水平下降。此外,Group 1 患者产后 CD8 T 细胞活化增强,特别是 TEMRA 亚群活化差异明显,表达穿孔素和颗粒酶 B 的 CD8 T 细胞频率增加。
CD8 T 细胞免疫特征的变化可能在产后肝炎发作患者免疫耐受打破中发挥一定作用,与激活和杀伤功能相关的指标可能有助于提示产后肝炎发作人群。